UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer

Current treatment options in oncology, 2021-12, Vol.22 (12), p.113-113, Article 113

2021

Volltextzugriff (PDF)

Up-to-date role of aflibercept in the treatment of colorectal cancer

Expert opinion on biological therapy, 2021-10, Vol.21 (10), p.1315-1324

2021

Volltextzugriff (PDF)

Carcinosarcoma of the upper urinary tract with an aggressive angiosarcoma component

Cancer biology & therapy, 2016-01, Vol.17 (3), p.233-236

2016

Volltextzugriff (PDF)

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer

Therapeutic Advances in Medical Oncology, 2020, Vol.12, p.175883592093608-1758835920936089

2020

Volltextzugriff (PDF)

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy

International journal of molecular sciences, 2022-12, Vol.24 (1), p.118

2022

Volltextzugriff (PDF)

Renal-cell carcinoma and multiple mieloma: synchronic association with posible immunologic pathogenesis

Medicina clinica, 2012-03, Vol.138 (5), p.224

2012

Volltextzugriff (PDF)

Outcome prognostic factors in inoperable malignant bowel obstruction

Supportive care in cancer, 2016-11, Vol.24 (11), p.4577-4586

2016

Volltextzugriff (PDF)

Non-Small Cell Lung Cancer (NSCLC) harboring Epidermal Growth Factor Receptor mutations (EGFR-m) and breast cancer (BC): A retrospective analysis of a single institution

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e19112-e19112

2015

Volltextzugriff (PDF)

Prognostic value of miR-196, IDO, and AXL in patients (p) with localized gastrointestinal stromal tumors (GIST)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.10553-10553

2014

Volltextzugriff (PDF)

Predictive value of integrative epigenetic profiling in metastatic melanoma (MM) patients (p) treated with BRAF/MEK inhibitors (BMI) and chemotherapy (CT)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20059-e20059

2015

Volltextzugriff (PDF)

Prevalence of ROS1 translocation, HER2, and BRAF mutations in a cohort of advanced Non-Small Cell Lung Cancer (NSCLC) patients (p) triple negative (TN)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e22139-e22139

2015

Volltextzugriff (PDF)

Second primary malignances (SPMs) in patients with gastrointestinal stromal tumors (GIST): The potential influence of imatinib treatment

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.10552-10552

2014

Volltextzugriff (PDF)

Patients (p) with advanced melanoma receiving rescue surgery (RS), BRAF inhibitors (BRAFi), immunotherapy (IT) or chemotherapy (CT) in an off-protocol, routine clinical setting

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e20046-e20046

2014

Volltextzugriff (PDF)

Absceso hepático: características clínicas, imagenológicas y manejo en el Hospital Loayza en 5 años

Revista de gastroenterología del Perú, 2010-01, Vol.30 (1), p.46-51

2010

Volltextzugriff (PDF)

Microembolismo Tumoral y Cor-Pulmonar como manifestación de Carcinoma Hepatocelular

Revista de gastroenterología del Perú, 2008-01, Vol.28 (1), p.70-73

2008

Volltextzugriff (PDF)

Carcinoma de células renales y mieloma múltiple: asociación sincrónica con posible patogenia inmunológica

Medicina clínica, 2012-03, Vol.138 (5), p.224-225

2012

Volltextzugriff (PDF)

Liver abscess: clinical, imaging and management features in a 5 year study in the Arzobispo Loayza National Hospital

Revista de gastroenterología del Perú, 2010-01, Vol.30 (1), p.46-51

2010

Volltextzugriff (PDF)

Carcinosarcoma of the upper urinary tract with an aggressive angiosarcoma component

Cancer Biology & Therapy, 2016, Vol.17 (3), p.233-236

2016

Volltextzugriff (PDF)

Tumoral microembolism and cor-pulmonar as manifestation of hepatocelular carcinoma

Revista de gastroenterología del Perú, 2008-01, Vol.28 (1), p.70-73

2008

Volltextzugriff (PDF)

Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis: A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils

Cancer biology & therapy, 2019-03, Vol.20 (3), p.237-239

2019

Volltextzugriff (PDF)

Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis

Cancer biology & therapy, 2019, Vol.20 (3), p.237

2019

Volltextzugriff (PDF)

Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis: A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils

Cancer Biology & Therapy, 2019, Vol.20 (3), p.237-239

2019

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer

Up-to-date role of aflibercept in the treatment of colorectal cancer

Carcinosarcoma of the upper urinary tract with an aggressive angiosarcoma component

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy

Renal-cell carcinoma and multiple mieloma: synchronic association with posible immunologic pathogenesis

Outcome prognostic factors in inoperable malignant bowel obstruction

Non-Small Cell Lung Cancer (NSCLC) harboring Epidermal Growth Factor Receptor mutations (EGFR-m) and breast cancer (BC): A retrospective analysis of a single institution

Prognostic value of miR-196, IDO, and AXL in patients (p) with localized gastrointestinal stromal tumors (GIST)

Predictive value of integrative epigenetic profiling in metastatic melanoma (MM) patients (p) treated with BRAF/MEK inhibitors (BMI) and chemotherapy (CT)

Prevalence of ROS1 translocation, HER2, and BRAF mutations in a cohort of advanced Non-Small Cell Lung Cancer (NSCLC) patients (p) triple negative (TN)

Second primary malignances (SPMs) in patients with gastrointestinal stromal tumors (GIST): The potential influence of imatinib treatment

Patients (p) with advanced melanoma receiving rescue surgery (RS), BRAF inhibitors (BRAFi), immunotherapy (IT) or chemotherapy (CT) in an off-protocol, routine clinical setting

Absceso hepático: características clínicas, imagenológicas y manejo en el Hospital Loayza en 5 años

Microembolismo Tumoral y Cor-Pulmonar como manifestación de Carcinoma Hepatocelular

Carcinoma de células renales y mieloma múltiple: asociación sincrónica con posible patogenia inmunológica

Liver abscess: clinical, imaging and management features in a 5 year study in the Arzobispo Loayza National Hospital

Carcinosarcoma of the upper urinary tract with an aggressive angiosarcoma component

Tumoral microembolism and cor-pulmonar as manifestation of hepatocelular carcinoma

Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis: A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils

Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis

Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis: A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils

Suchergebnisse filtern